About heather

This author has not yet filled in any details.
So far heather has created 733 blog entries.

Counterfeit drugs: why on-dose authentication offers the most viable solution

Counterfeit drugs: why on-dose authentication offers the most viable solution (part I) Leading excipient and film coating manufacturer Colorcon has developed a solution to help in the fight against fake drugs through the inclusion of taggants embedded onto individual pills … and the use of smart readers to track and verify branded/authentic products [...]

2022-11-04T10:44:16-04:00Categories: APDN in the News|Tags: , |

Beyond Serialization

By Gary Pond | December 10, 2020 With the World Health Organisation reporting that over half of all drugs purchased from online pharmacies are suspected counterfeit, and the number of illegal online pharmacies increasing dramatically since the start of the COVID-19 pandemic, there is a growing recognition that serialisation alone will not [...]

2022-11-04T10:45:52-04:00Categories: APDN in the News|Tags: , |

NY Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program

STONY BROOK, N.Y. December 11, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its Applied DNA Clinical Laboratories, LLC (ADCL) subsidiary is experiencing growing demand for its safeCircle™ pooled COVID-19 surveillance testing program that is [...]

rPET FAQ

CertainT® is an integrated supply chain platform for verifying authenticity of r-PET items from source to retail shelf. The three pillars of the platform, Tag, Test, and Track, enable brands and manufacturers to preserve the integrity and quality of the r-PET in their supply chain. Consumers will have [...]

2023-03-06T11:15:36-05:00Categories: Synthetics, Textile and Apparel|Tags: , |

APDN FY’20 Q4 Financial Results Advisory

STONY BROOK, NY. December 8, 2020. Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it will release financial results for its fiscal 2020 fourth quarter ended September 30, 2020 after market close on Thursday, December 17, 2020. [...]

2022-10-28T12:04:31-04:00Categories: Press Release|Tags: , |

Nutrition21 Transitions to CertainT® Platform to Secure Portfolio of Dietary Supplement Ingredients

STONY BROOK, N.Y. December 7, 2020. Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced the expansion of commercial activities under its multi-year Master Services Agreement (MSA) with Nutrition21 whereby Nutrition21 has transitioned to Applied DNA’s CertainT® platform [...]

2024-03-04T13:57:45-05:00Categories: Press Release|Tags: , , |

CertainT for Cotton FAQ

CertainT® is an integrated supply chain platform for verifying authenticity of cotton items from source to retail shelf. The three pillars of the platform, Tag, Test, and Track, enable brands and manufacturers to preserve the integrity and quality of the cotton in their supply chain. Consumers will [...]

2023-05-15T10:38:08-04:00Categories: Cotton, Textile and Apparel|Tags: |

Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball

STONY BROOK, N.Y. – December 1, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced that its wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC (“ADCL”), will provide its COVID-19 surveillance testing program to the Stony Brook University Seawolves [...]

APDN, Evvivax and GVS Receive Approval for Veterinary COVID-19 Clinical Trial

STONY BROOK, N.Y. – November 30, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, EvviVax, S.R.L. (“EvviVax”), a spin-off of Takis Biotech with expertise in engineered veterinary cancer immunotherapy and targeted vaccines, and Veterinary Oncology Services at [...]

Go to Top